Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2026 Jul 13;17:1917753. doi: 10.3389/fimmu.2026.1917753

Correction: HLA-G expression in non-small cell lung cancer: prognostic significance and interplay with PD-L1 and CD8+ tumor-infiltrating lymphocytes

Giulia Querzoli 1,†, Giuseppe Bogina 2,†, Marcella Marconi 2, Nicola Tumino 3, Paola Vacca 3, Luisella Righi 4, Sara Pilotto 5, Anna Caliò 6, Luca Cima 7, Stefano Gobbo 6, Matthew J Cecchini 8, Gaetano Paolino 9, Francesco Ciompi 10, Roberto S Accolla 11, Aldo Scarpa 6, Gianluigi Lunardi 12, Emanuela Marcenaro 13,14, Lorenzo Moretta 15, Giuseppe Zamboni 2, Enrico Munari 7,*
PMCID: PMC13403000  PMID: 42516371

The funder European Union – Next Generation EU – NRRP M6C2 – Investment 2.1 “Enhancement and strengthening of biomedical research in the NHS” by the Italian Ministry of Health, PNRR-POC-2023-12377131, to PV and EM was erroneously omitted.

The original version of this article has been updated.

Footnotes

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES